title: Development and optimization of buspirone oral osmotic pump tablet.
abstract: The aim of the current study was to design a porous osmotic pump-based drug delivery system for controlling the release of buspirone from the delivery system. The osmotic pump was successfully developed using symmetric membrane coating. The core of the tablets was prepared by direct compression technique and coated using dip-coating technique. Drug release from the osmotic system was studied using USP paddle type apparatus. The effect of various processing variables such as the amount of osmotic agent, the amount of swellable polymer, concentration of the core former, concentration of the plasticizer, membrane thickness, quantum of orifice on drug release from osmotic pump were evaluated. Different kinetic models (zero order, first order and Higuchi model) were applied to drug release data in order to establish the kinetics of drug release. It was found that the drug release was mostly affected by the amount of NaCl as osmotic agent, the swellable polymer; hydroxy propyl methyl cellulose (HPMC), the amount of PEG-400 and cellulose acetate in the coating solution and thickness of the semipermeable membrane. The optimized formulation released buspirone independent of pH and orifice quantum at the osmogen amount of 42%, hydrophilic polymer of 13% and pore size of 0.8 mm on the tablet surface. The drug release of osmotic formulation during 24 h showed zero order kinetics and could be suggested that this formulation as a once-daily regimen improves pharmacokinetic parameters of the drug and enhances patient compliance.
authors: Department of Pharmaceutics, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran ; Nano Drug Delivery Research Center, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
authors: K
authors: K
authors: Derakhshandeh
authors: Department of Pharmaceutics, Faculty of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran ; Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, I.R. Iran.
authors: M Ghasemnejad
authors: MG
authors: Berenji
keywords: Buspirone; Controlled release; Osmotic pump; Release kinetic
references: J Control Release. 2003 Apr 14;89(1):5-18
references: 12695059
references: J Pharm Sci. 1975 Dec;64(12):1987-91
references: 1510
references: Int J Pharm. 2000 Sep 15;205(1-2):195-8
references: 11000556
references: Eur J Pharm Biopharm. 2008 Feb;68(2):289-97
references: 17616378
references: J Control Release. 2004 Jan 8;94(1):75-89
references: 14684273
references: J Control Release. 2000 Jul 3;67(2-3):309-22
references: 10825563
references: Int J Pharm. 2000 Jan 5;193(2):147-56
references: 10606777
references: Drug Dev Ind Pharm. 2002 Jan;28(1):77-87
references: 11858527
references: Eur J Pharm Biopharm. 2007 Nov;67(3):725-31
references: 17543513
references: Curr Drug Deliv. 2009 Jan;6(1):130-9
references: 19418965
references: J Basic Clin Pharm. 2012 Dec;4(1):2-9
references: 24808662
references: J Pharm Sci. 1983 Mar;72(3):253-8
references: 6842377
references: Int J Pharm. 2004 Oct 13;284(1-2):95-108
references: 15454301
references: Drug Dev Ind Pharm. 2000 Jul;26(7):695-708
references: 10872087
references: J Clin Pharmacol. 2001 Jul;41(7):783-9
references: 11452712
references: Aust J Exp Biol Med Sci. 1955 Aug;33(4):415-9
references: 13269346
references: Eur J Pharm Biopharm. 2006 Oct;64(2):180-4
references: 16797951
references: AAPS PharmSciTech. 2007 Jul 13;8(3):E53
references: 17915803